Jorge M Blando (Jorge Blando)

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 3

Top Topics

Binding Protein

Small Cell Lung Cancer

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

Science translational medicine

Cancer discovery

This page only lists publications with an associated author ORCID identifier.

Publications

Cascone Tina, Gozde Kar, Jonathan D Spicer, María Del Rosario García-Campelo, Walter Weder, Davey B Daniel, David R Spigel, Maen Hussein, Julien Mazieres, Júlio Oliveira, Edwin H Yau, Alexander I Spira, Valsamo Anagnostou, Raymond Mager, Oday Hamid, Lin-Yang Cheng, Ying Zheng, Jorge M Blando, Tze Heng Tan, Michael Surace, Jaime Rodriguez-Canales, Vancheswaran Gopalakrishnan, Bret R Sellman, Italia Grenga, Yee Soo-Hoo, Rakesh Kumar, Lara McGrath, Patrick M Forde
Neoadjuvant Durvalumab Alone or Combined with Novel Immuno-Oncology Agents in Resectable Lung Cancer: The Phase 2 NeoCOAST Platform Trial. Cancer discovery (2023)
Martin H Voss, Arun A Azad, Aaron Richard Hansen, Jhanelle E Gray, Sarah J Welsh, Xuyang Song, Michael Kuziora, Lina Meinecke, Jorge M Blando, Ikbel Achour, Yi Wang, Farzana L Walcott, Sjoukje F Oosting
A Randomized Phase II Study of MEDI0680 in Combination with Durvalumab versus Nivolumab Monotherapy in Patients with Advanced or Metastatic Clear-cell Renal Cell Carcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (14) (2022)
Sangeeta Goswami, Yulong Chen, Swetha Anandhan, Peter M Szabo, Sreyashi Basu, Jorge M Blando, Wenbin Liu, Jan Zhang, Seanu Meena Natarajan, Liangwen Xiong, Baoxiang Guan, Shalini Singh Yadav, Abdel Saci, James P Allison, Matthew D Galsky, Padmanee Sharma
ARID1A mutation plus CXCL13 expression act as combinatorial biomarkers to predict responses to immune checkpoint therapy in mUCC. Science translational medicine 12 (548) (2021)